Medtronic (MDT) Scheduled to Post Earnings on Thursday

Medtronic (NYSE:MDT) will announce its earnings results before the market opens on Thursday, May 23rd. Analysts expect the company to announce earnings of $1.47 per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.

Medtronic (NYSE:MDT) last issued its earnings results on Tuesday, February 19th. The medical technology company reported $1.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.05. Medtronic had a net margin of 16.10% and a return on equity of 13.85%. The firm had revenue of $7.55 billion for the quarter, compared to analysts’ expectations of $7.53 billion. During the same quarter last year, the business earned $1.17 earnings per share. The business’s revenue was up 2.4% on a year-over-year basis. On average, analysts expect Medtronic to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Shares of Medtronic stock opened at $87.77 on Wednesday. The company has a current ratio of 2.36, a quick ratio of 1.92 and a debt-to-equity ratio of 0.47. Medtronic has a 52-week low of $81.66 and a 52-week high of $100.15. The company has a market capitalization of $117.66 billion, a PE ratio of 18.40, a PEG ratio of 2.18 and a beta of 0.78.



MDT has been the topic of several recent analyst reports. Needham & Company LLC reiterated a “strong-buy” rating and issued a $117.00 price target (down previously from $120.00) on shares of Medtronic in a report on Monday, February 4th. Oppenheimer set a $104.00 price target on shares of Medtronic and gave the company a “buy” rating in a report on Wednesday, February 20th. Wells Fargo & Co cut their price target on shares of Medtronic from $101.00 to $100.00 and set a “market perform” rating on the stock in a report on Thursday, April 4th. Citigroup lifted their price target on shares of Medtronic from $95.00 to $101.00 and gave the company a “neutral” rating in a report on Monday, February 25th. Finally, Barclays reiterated a “buy” rating and issued a $104.00 price target on shares of Medtronic in a report on Wednesday, February 20th. Ten equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $103.39.

ILLEGAL ACTIVITY NOTICE: This story was posted by Dakota Financial News and is owned by of Dakota Financial News. If you are viewing this story on another publication, it was illegally stolen and republished in violation of U.S. & international trademark & copyright law. The correct version of this story can be viewed at https://dakotafinancialnews.com/2019/05/22/medtronic-mdt-scheduled-to-post-earnings-on-thursday.html.

Medtronic Company Profile

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group.

See Also: Outstanding Shares, Buying and Selling Stocks

Earnings History for Medtronic (NYSE:MDT)

Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.